Searched for
PHARMA SECTOR
Beyond tech: Kotak MF’s Shibani Kurian on India’s next innovation-led winnersInnovation-led investment opportunities in India are extending well beyond technology, with healthcare, auto components and industrials eme...
Bonus issue alert! Last day to buy this Rakesh Jhunjhunwala-backed smallcap pharma stock for 1:1 bonus bonanzaAs per Sebi's T+1 settlement cycle, investors must buy the company's shares at least one trading day before the record date for them to be ...
Market wrap: RIL, Tata Steel, Infosys, ICICI Bank top gainers and losers on Nifty and Sensex on MondayIndian markets rallied sharply, with Sensex gaining 1.66% to 75,693 and Nifty rising 1.68% to 23,441. Strong quarterly earnings lifted inve...
Technology funds top October returns with gains of up to 10%. Is it the right time to invest?Technology mutual funds topped October returns, with the nine best-performing schemes delivering gains of up to 9.78%, an ETMutualFunds ana...
Diwali investment picks 2026: 10 fund managers reveal promising opportunities and risks to watchThis Diwali, investment experts advise a strategic approach focused on asset allocation rather than luring high-growth stocks. Sectors like...
Diwali 2026: 77 stocks knock down D-St bears to deliver multibagger returns of up to 4,700% in a yearWith Diwali 2026 on the horizon, 77 stocks have thrived despite market fluctuations, marking exceptional returns. Mrugesh Trading showcases...
Climate platform Two Point O raises $10 million led by Transition Venture CapitalThe company plans to enter battery energy storage while expanding its existing offerings in solar power, energy efficiency, and wastewater ...
India’s medicine sales grow in double digits for four straight quarters, led by chronic care drugsOver the past four quarters, India's medicine sales have increased significantly due to rising demand in chronic care segments. The growth ...
F&O Talk: Big break above 23,200 can open doors for 23,500 for Nifty; Sudeep Shah picks 6 stocks ahead of DiwaliNifty could extend its recovery towards 23,500 if it decisively breaks above the 23,150–23,200 resistance zone, says SBI Securities' Sudeep...
Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosyst...
Dalal Street Weak Ahead: Nifty stands on firmer footing, but can it break past 23,450?The Nifty gained 2% last week, recovering above the crucial 200-week moving average at 22,700. While easing volatility and buying at lower ...
Market wrap: Shriram Finance, Nestle India, Trent, InterGlobe top gainers and losers on Nifty and Sensex on FridayThe Nifty 50 rose 0.51% to close at 23,053.10 on Friday, while the Sensex gained 308 points to 74,459.53. Trent and InterGlobe led the gain...
Sensex rises 308 points, Nifty above 23,000 even as broader markets crash. Will D-Street bulls extend recovery next week?Indian market indices Sensex and Nifty ended the week on a high note, each climbing by up to 0.5%. Even as the broader market suffered loss...
India, Mexico begin talks for trade pact; aim to boost commerce, investmentsIndia and Mexico have initiated negotiations for a preferential trade agreement to enhance bilateral trade and investment. The agreement ai...
Sensex, Nifty close flat while small, midcaps rally. What analysts are saying?During a day marked by volatility, Indian stock market indices Sensex and Nifty concluded with minor dips, primarily due to oil prices near...
Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 croreMankind Pharma shares jumped nearly 8% after the company reported a 38% year-on-year rise in Q2 profit to Rs 716 crore. Revenue grew 17%, s...
Indian pharma: Unethical practices, marketing rules under lens; new review body set upThe review comes against the backdrop of the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), which was introduced in 2015 as a...